KMID : 1040020230140010018
|
|
International Journal of Pain 2023 Volume.14 No. 1 p.18 ~ p.22
|
|
The Effect of Mirogabalin on the Treatment of Intractable Postherpetic Neuralgia Not Responding Appropriately to Pregabalin: A Case Report
|
|
Jeong Jeong
Hwang In-Eob Woo Sung-Won Moon Jee-Youn
|
|
Abstract
|
|
|
Postherpetic neuralgia (PHN) is the most common but challenging complication of herpes zoster due to long-lasting intractable neuropathic pain. Routine pharmacologic treatments of PHN include anticonvulsants (e.g., gabapentin, pregabalin), antidepressants (e.g., amitriptyline), opioids (e.g., oxycodone, morphine). However, those medications have limitations due to side effects inclusive of peripheral edema, nausea, vomiting and somnolence, or insufficient analgesic effect. Mirogablin, a novel voltage-gated calcium channel (VGCC) selective ¥á2¥ä ligand, has been recently approved as a drug to treat peripheral neuropathic pain. In this case report, we represent a 77-year-old patient with intractable PHN who achieved successful pain relief with intake of mirogabalin with less side effects.
|
|
KEYWORD
|
|
anticonvulsant, gabapentinoid, mirogabalin, neuropathic pain, postherpetic neuralgia
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|